ALK and non-small cell lung carcinoma: Finally, while CTC count can have prognostic value in ALK+ NSCLC, CTCs can also be used to shed light on drug resistance mechanisms: an L1196M mutation (Table 2) was found by CTC gene sequencing in the peripheral blood of patients with acquired resistance to crizotinib [116].